Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Ettingshausen · SciRah

Researcher profile · Semantic Scholar

C. Ettingshausen

Share profile

C. Ettingshausen — researcher profile on SciRah

h-index: 21
Works: 69
Citations: 1,499

Most-cited papers

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review
A. Iorio, S. Halimeh, S. Holzhauer, N. Goldenberg +15 more
2010Journal of Thrombosis and Haemostasis280 citations Open access
Semantic Scholar
Symptomatic Onset of Severe Hemophilia A in Childhood is Dependent on the Presence of Prothrombotic Risk Factors
C. Ettingshausen, S. Halimeh, K. Kurnik, R. Schobess +5 more
2001Thrombosis and Haemostasis142 citations
Semantic Scholar
Replacement Therapy with Protein C Concentrate in Infants and Adolescents with Meningococcal Sepsis and Purpura Fulminans
C. Ettingshausen, A. Veldmann, T. Beeg, W. Schneider† +2 more
1999Seminars in Thrombosis and Hemostasis107 citations
Semantic Scholar
Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.
W. Kreuz, C. Ettingshausen, A. Zyschka, J. Oldenburg +3 more
2002Seminars in Thrombosis and Hemostasis95 citations
Semantic Scholar
Epidemiology of inhibitors and current treatment strategies.
W. Kreuz, C. Ettingshausen, G. Auerswald, I. Saguer +5 more
2003Haematologica94 citations
Semantic Scholar
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement
A. Iorio, E. Iserman, V. Blanchette, G. Dolan +11 more
2017Haemophilia85 citations
Semantic Scholar
Role of von Willebrand factor in immune tolerance induction
C. Ettingshausen, W. Kreuz
2005Blood Coagulation and Fibrinolysis72 citations
Semantic Scholar
Recombinant vs. plasma‐derived products, especially those with intact VWF, regarding inhibitor development
C. Ettingshausen, W. Kreuz
2006Haemophilia62 citations
Semantic Scholar
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study
W. Kreuz, C. Ettingshausen, V. Vdovin, N. Zozulya +20 more
2016Haemophilia58 citations Open access
Semantic Scholar
Early long‐term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series
C. Ettingshausen, W. Kreuz
2010Haemophilia51 citations
Semantic Scholar
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
M. Riedl, M. Maurer, J. Bernstein, A. Banerji +68 more
2020Allergy. European Journal of Allergy and Clinical Immunology45 citations Open access
Semantic Scholar
Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy
C. Ettingshausen, I. Saguer, W. Kreuz
1999European Journal of Pediatrics43 citations
Semantic Scholar
Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children – results of a multicenter study
K. Kurnik, W. Kreuz, S. Horneff, C. During +6 more
200737 citations Open access
Semantic Scholar
Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease.
C. Ettingshausen, K. Kurnik, R. Schobess, W. Kreuz +3 more
2002Blood34 citations
Semantic Scholar
Inhibitors in patients with haemophilia A.
W. Kreuz, C. Ettingshausen
2014Thrombosis Research30 citations
Semantic Scholar
New findings on inhibitor development: from registries to clinical studies
F. Peyvandi, C. Ettingshausen, J. Goudemand, V. Jiménez-Yuste +2 more
2017Haemophilia29 citations
Semantic Scholar
Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys.
K. Kurnik, W. Kreuz, S. Horneff, C. During +6 more
2007Haematologica28 citations
Semantic Scholar
The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?
C. Ettingshausen, W. Kreuz
2013Haemophilia26 citations
Semantic Scholar
Common themes and challenges in hemophilia care: a multinational perspective
J. Stoffman, N. G. Andersson, B. Branchford, K. Batt +9 more
2018Hematology24 citations Open access
Semantic Scholar
Neonatal Sepsis: A Challenge in Hemostaseology
W. Kreuz, A. Veldmann, D. Fischer, R. Schlößer +2 more
1999Seminars in Thrombosis and Hemostasis23 citations
Semantic Scholar
Achievements, challenges and unmet needs for haemophilia patients with inhibitors
Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer +11 more
2016Haemophilia21 citations Open access
Semantic Scholar
A review of immune tolerance induction with Haemate® P in haemophilia A
C. Ettingshausen, W. Kreuz
2014Haemophilia14 citations Open access
Semantic Scholar
Spotlight on the human factor: building a foundation for the future of haemophilia A management
Craig M. Kessler, J. Oldenburg, C. Ettingshausen, A. Tiede +3 more
2015Haemophilia11 citations
Semantic Scholar
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
Douglas T. Johnston, P. Busse, M. Riedl, M. Maurer +67 more
2021Clinical and Experimental Allergy9 citations Open access
Semantic Scholar
Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?
A. Veldman, A. Ehrenberg, Gudrun Jäger, C. Ettingshausen +2 more
2000Critical Care Medicine9 citations
Semantic Scholar
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.
M. Albisetti, Jesús Ardila, J. Astermark, Jan Blatný +45 more
2024Haemophilia8 citations Open access
Semantic Scholar
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
C. Ettingshausen, C. Hermans, P. Holme, A. Cid +6 more
2023Therapeutic Advances in Hematology8 citations Open access
Semantic Scholar
Abstracts from the 10th C1-inhibitor deficiency workshop
A. Schmaier, M. Cicardi, A. Reshef, D. Moldovan +337 more
2017Allergy, Asthma & Clinical Immunology8 citations Open access
Semantic Scholar
Prevention of joint damage in hemophilic children with early prophylaxis
W. Kreuz, C. Ettingshausen, M. Funk, S. Pons +2 more
1999Der Orthopade7 citations
Semantic Scholar
The Role of Age at First Exposure and Therapy Regimen on the Development of Neutralizing FVIII Antibodies in Hemophilia A.
C. Ettingshausen, A. Zyschka, I. Saguer, C. Heller +2 more
20046 citations
Semantic Scholar
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
C. Pfrepper, C. Ettingshausen, R. Klamroth, J. Oldenburg +1 more
2024Hämostaseologie5 citations
Semantic Scholar
Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products
W. Kreuz, C. Ettingshausen, Alex Zyschka, J. Oldenburg +3 more
20025 citations
Semantic Scholar
Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update
C. Ettingshausen, R. Lassila, G. Escolar, C. Male +3 more
2025Haemophilia4 citations Open access
Semantic Scholar
Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study.
G. Kenet, C. Bidlingmaier, N. Bogdanova, C. Ettingshausen +8 more
2014Thrombosis Research4 citations Open access
Semantic Scholar
Long-term aspects of hemophilia B treatment: part I—role for prophylaxis
C. Ettingshausen, W. Kreuz
2004Blood Coagulation and Fibrinolysis4 citations
Semantic Scholar
octanate®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment
A. Klukowska, V. Komrska, V. Vdovin, N. Zozulya +3 more
2020Therapeutic Advances in Hematology3 citations Open access
Semantic Scholar
Pharmacokinetic model-based assessment of factor IX prophylaxis treatment regimens in severe hemophilia B
B. Vandewalle, G. Castaman, M. Álvarez-Román, C. Ettingshausen +5 more
2024Scientific Reports2 citations Open access
Semantic Scholar
florio® HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe
Ester Zapotocka, Angelika Batorova, Ernest Bilic, A. Boban +9 more
2024Advances in Therapy2 citations Open access
Semantic Scholar
Successful management of hereditary angioedema during pregnancy in a patient with heterozygous MTHFR mutation.
I. Saguer, C. Ettingshausen
20172 citations
Semantic Scholar
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
Christian Pfrepper, R. Klamroth, C. Ettingshausen, Sirak Petros +2 more
2024Haemophilia1 citations Open access
Semantic Scholar
Target plasma factor levels for personalized treatment in hämophilia: a Delphi consensus statement
A. Iorio, E. Iserman, V. Blanchette, G. Dolan +11 more
20171 citations
Semantic Scholar
Influence of Factor V G1691A or Prothrombin G20210A Mutation On Inhibitor Development in Patients with Severe Hemophilia A - an Israeli-German Database Study.
G. Kenet, C. Bidlingmaier, C. Ettingshausen, S. Gutsche +4 more
20121 citations
Semantic Scholar
Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study.
K. Kurnik, S. Halimeh, Daniela Manner, S. Holzhauer +3 more
20091 citations
Semantic Scholar
The Role of Therapy Regimen and Age at First Exposure on Inhibitor Development in Patients with Severe Hemophilia A
C. Ettingshausen, R. Linde, I. Saguer, A. Zyschka +3 more
20051 citations
Semantic Scholar
PB1451 Immune Tolerance Induction in Haemophilia A Patients with Inhibitors: Updated Analysis from MOTIVATE
C. Ettingshausen, R. Sidonio
2026Research and Practice in Thrombosis and Haemostasis0 citations Open access
Semantic Scholar
Extravascular distribution of factor IX: evidence and relevance for hemophilia B replacement therapy
C. Hermans, C. Ettingshausen, M. Laffan, D. Matino +3 more
2026Hämostaseologie0 citations
Semantic Scholar
OC 35.4 Inhibitor development during emicizumab prophylaxis in previously treated patients with severe hemophilia A (less than 50 exposure days)
V. Labarque, Christoph Male, G. Kenet, S. Levy-Mendelovich +12 more
2026Research and Practice in Thrombosis and Haemostasis0 citations Open access
Semantic Scholar
PB1500 Eptacog Beta for Prevention of Bleeding During Surgery in Patients with Haemophilia A and Inhibitors: A German Case Series
Georg Goldmann, Natascha Marquardt, C. Ettingshausen, S. Gottstein +2 more
2026Research and Practice in Thrombosis and Haemostasis0 citations Open access
Semantic Scholar
FVIII exposure, bleeding outcomes, and inhibitor development in 80 PUPs and MTPs with severe hemophilia A on emicizumab prophylaxis: real world data from the PedNet Registry.
M. de Kovel, G. Kenet, J. Motwani, Nadine G. Andersson +13 more
2026Journal of Thrombosis and Haemostasis0 citations
Semantic Scholar
OC 02.5 Mim8 (denecimig) prophylaxis in children with haemophilia A with or without inhibitors: Interim safety and efficacy results from the FRONTIER4 long-term extension study
M. Carcao, M. Chitlur, K. Fijnvandraat, I. Frandsen +4 more
2026Research and Practice in Thrombosis and Haemostasis0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Kreuz×19
Invite
W. Kreuz — researcher profile on SciRah
J. Oldenburg×10
Invite
J. Oldenburg — researcher profile on SciRah
G. Kenet×8
Invite
G. Kenet — researcher profile on SciRah
K. Kurnik×8
Invite
K. Kurnik — researcher profile on SciRah

U. Nowak-Göttl

×8

Invite

U. Nowak-Göttl — researcher profile on SciRah

Invite

I. Saguer — researcher profile on SciRah

Invite

S. Halimeh — researcher profile on SciRah

C. Bidlingmaier×5

Invite

C. Bidlingmaier — researcher profile on SciRah

Invite

C. Négrier — researcher profile on SciRah

Invite

R. Klamroth — researcher profile on SciRah

T. Klingebiel×4

Invite

T. Klingebiel — researcher profile on SciRah

Invite

W. Kreuz — researcher profile on SciRah